Dementia with Depression A Diagnostic Challenge Louis A. Cancellaro, PHD, MD Professor Emeritus Interim Chair March 26, 2012 Epidemiology Inexact diagnosis compromises research Major depressive disorder (MDD) either precedes or co-exists with Alzheimer’s Disease (AD) occurs more frequently than can be explained by chance alone Prevalence rates: -MDD in non-demented patients>60yo =0.6-8% -MDD in AD (age/sex matched)=15-30% Epidemiology ≤ 60% of non-demented elderly patients with severe depression are later diagnosed with AD (@ 3 yr. follow-up) Elderly patients with MDD + mild cognitive decline are twice as likely to develop AD than those without mild cognitive decline, who had no greater incidence of AD (@12 yr. follow-up) Etiology of Depression in AD Psychological • Grief over loss of cognitive function Biological • Analogous to stroke, especially dominant hemisphere, where MDD is prevalent and is responsive to anti-depressants • AD has associated deterioration of locus ceruleus, which is purportedly disrupted in MDD, as well Diagnosis Diagnosing depression in elderly • Inexact • Part of a continuum • Sadness ↔ MDD ↔ Psychotic Depression • Frequently presents with somatic symptoms as opposed to classical DSM IV criteria Diagnosis Diagnosing depression in elderly • Use family + patient for history • Report >2 weeks history of (one or more): • Loss of energy, loss of interests • Increase in somatic symptoms w/o adequate physical explanation • Behavioral and/or personality change • Suicidal tendencies • Delusions Diagnosis Diagnosing depression in elderly • No precise diagnostic tests • Biochemical • Radiological • Psychological Hamilton Depression Rating Scale DSM-IV Experienced clinicians are the most help Diagnosis Diagnosing AD in elderly with MDD • History of cognitive decline beyond just loss of concentrating ability • Patient may, or may not, complain of memory loss • Cognitive psychological tests • Mini-mental status • Full battery Diagnosis Diagnosing depression and AD in elderly Even more inexact, especially if signs of AD not previously recognized MDD in elderly frequently presents with personality change and/or somatic symptoms • • • • • Behavioral change Loss of concentrating ability; poor judgment Vague physical symptoms Loss of energy “Nerves” Diagnosis Depression + AD in elderly • Difficult to make a dual diagnosis • Serious risks associated with a missed diagnosis • Thus, the clinician must consider the coexistence of both conditions if one is present, until proven otherwise Epidemiology Suicide risk: For all patients 65 years of age vs <65: • Rate =50% higher • Lethality =1 out of 2 attempts vs1 out of 8 Diagnosis Depression in elderly with AD Use family + patient for history Report 2 weeks history of (one or more): Loss of energy, loss of interests Increase in somatic symptoms w/o adequate physical explanation Behavioral and/or personality change Suicidal tendencies Delusions Dementia and Depression: Distinguishing Features Feature Dementia Onset Unclear, insidious Progression Patient insight Affect Test Performance Depression Clear, recent, often a major psychotic event Relatively steady decline Uneven, often no progression Often unaware of deficits, Nearly always aware of not distressed deficits and quite distressed Bland, some lability Marked disturbance Good cooperation and Poor cooperation and effort, stable achievement, effort, variable little test anxiety, “near achievement, considerable miss” responses anxiety, “don’t know” responses Short-term memory Often impaired Sometimes impaired Long-term memory Unimpaired early in disease Often inexplicably impaired Differential Diagnosis Endocrine Thyroid disease Diabetes Mellitus Cushing’s Addison’s Hyperparathyroidism Cardiovascular and pulmonary disease MI Congestive heart failure COPD Differential Diagnosis Endocrine Cardiovascular and pulmonary disease Anemia • B12 Kidney and liver disease Hepatitis C Infections AIDS, TB, hepatitis, chronic fatigue syndrome, other chronic infections Differential Diagnosis Endocrine Cardiovascular and pulmonary disease Anemia Kidney and liver disease Infections Neurological disease CVA, low pressure hydrocephalus, Parkinson’s, subdural hematoma, sleep apnea, brain tumor, seizure disorder Differential Diagnosis Medication side effects and interactions Psychotropics Benzodiazepines Anti-psychotics Anti-convulsants Anti-depressants Sleeping agents Pulmonary and cardiac drugs Steroids Differential Diagnosis Medication side effects and interactions Occult malignancy Lymphomas, leukemias, multiple myeloma Retro-peritoneal tumors Collagen vascular disease SLE, polymyalgia rheumatica, rheumatoid arthritis, scleroderma, fibromyalgia Medications used in treatment Alcoholism Other psychiatric disorders Anxiety disorders Mania Evaluation and Management Suspecting MDD either preceding or coexisting with AD History (from patient and family) Chief Complaint “Depressed” (less common) “Nerves” “Memory loss” Somatic symptoms (↓energy, GI symptoms, weakness) Evaluation and Management History Chief Complaint Course of illness (one or more): 2 weeks ↓interest in daily activities ↓cognitive ability Personality change with impulsiveness Suicidal tendencies Evaluation and Management History Assessment • Lack of medical condition sufficient to explain signs • • • • • • and symptoms Patient more detached than usual Meets most of DSM-IV criteria for MDD↓Performance on cognitive tests If AD present, caregivers report ↑frustration, ↑ hopelessness in themselves Suicide risk factors reviewed with patient and family Domestic violence risk factors reviewed Review differential diagnosis, especially medication side effects and interactions Evaluation and Management History Assessment Treatment: MDD in elderly patients with AD • Medications • Anti-depressants → • ≤85% improvement in mood if MDD present • Plus occasional improvement in cognition • No improvement in mood or cognition if MDD is not present Evaluation and Management History Assessment Treatment: MDD in elderly patients with AD Medications: • Anti-depressants: low doses, increase slowly • SSRI’s (1/4-1/2 normal starting dose) • Fluoxetine (Prozac®) • Sertraline (Zoloft®) • Paroxetine (Paxil®) • • • SSRI’s + donepezil (Aricept ®) = safe SSRI’s + other meds may alter metabolism TCA’s not well tolerated Evaluation and Management History Assessment Treatment: MDD in elderly patients with AD Medications continued • Anti-psychotics → • ↓ agitation and violent risk • • • • ↓ delusions Risperdone (Risperdal®) 0.25-1.0 mg/d Haloperidol (Haldol®) 0.5-2.0 mg/d Olanzapine (Zyprexa®) 2.5-10 mg/d Evaluation and Management History Assessment Treatment: MDD in elderly patients with AD Medications • Anti-depressants • Anti-psychotics • Anti-convulsants • Minor tranquilizers → • ↓ anxiety • ↑ sedation • ↓ cognition Evaluation and Management History Assessment Treatment: MDD in elderly patients with AD Medications Psychotherapy (slow, repetitive process) • Supportive • Behavior (statistically significant improvement) • Family (especially with caregivers) Evaluation and Management History Assessment Treatment: MDD in elderly patients with AD Medications Psychotherapy Management of suicidal behavior Frequent assessment ECT may be required Summary MDD frequently precedes or co-exists with AD Diagnosis of MDD in elderly is inexact If MDD + AD is suspected, effective treatment of the MDD can not only improve the mood and behavior of the patient, but also improve condition